Venture capital firms are the lifeblood of many biotech startups, providing not only vital financial resources but also operational expertise. This article dives into ten prominent venture capital arms established
News & Updates
A new report by the Expert Group on Future Skills Needs (EGFSN) predicts significant growth in Ireland's biopharmaceutical industry. The report, titled "Skills for Biopharma," estimates the creation of 21,000-26,000
The European Medicines Agency (EMA) has released a revised question-and-answer document to aid manufacturers, regulators, and notified bodies involved with medical devices used alongside medications. This document offers practical guidance
Researchers are exploring a novel approach combining a genetically modified herpes virus with a cancer vaccine. This combination therapy holds promise for treating aggressive childhood cancer.
Bayer presented promising data from their Phase III OASIS clinical trials on Elinzanetant, a potential new weapon in the fight against hot flashes and other menopause symptoms. Elinzanetant is a
Semaglutide, a medication initially used for type 2 diabetes, has emerged as a potential game-changer in various healthcare fields. Let's explore its expanding horizon:
Pfizer is venturing into the direct-to-consumer healthcare space with its "Pfizer for All" platform. This initiative follows the success of Eli Lilly's "LillyDirect" platform, marking a trend in pharmaceutical companies
These ten healthcare stocks are currently trading below their fair value estimates, presenting potential buying opportunities for investors seeking exposure to the growing healthcare sector. Let's delve deeper into each
The National Institutes of Health (NIH) is launching new clinical trials to investigate treatments for common long COVID symptoms. These trials are part of the ongoing NIH RECOVER Initiative, which
The pharma services sector is a hotbed for investment, according to Jay Ferguson, director at Houlihan Lokey's Healthcare Group. He predicts a surge in demand driven by a confluence of
The pharmaceutical industry is on the cusp of a major transformation driven by digitalization. This era, known as Pharma 4.0 or the "Smart Factory," leverages cutting-edge technologies like Artificial Intelligence
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) announced the successful completion of their Phase 2 study (MP18) in Europe. This open-label study examined the feasibility and safety of using MDMA